Business Description
![Merck KGaA Merck KGaA logo](https://static.gurufocus.com/logos/0C00000UH9.png?14)
Merck KGaA
NAICS : 325412
SIC : 2834
ISIN : DE0006599905
Share Class Description:
XTER:MRK: Ordinary SharesCompare
Compare
Traded in other countries / regions
MRK.Germany0O14.UKMKKGY.USA1MRK.ItalyMRK1.MexicoMRCK.AustriaMRK.BulgariaMER.Switzerland IPO Date
1995-10-20Description
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.25 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.36 | |||||
Debt-to-EBITDA | 1.78 | |||||
Interest Coverage | 10.06 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.15 | |||||
Beneish M-Score | -2.56 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.2 | |||||
3-Year EBITDA Growth Rate | 4.7 | |||||
3-Year EPS without NRI Growth Rate | 15.8 | |||||
3-Year FCF Growth Rate | -2.7 | |||||
3-Year Book Growth Rate | 16.3 | |||||
Future 3-5Y EPS without NRI Growth Rate | 18.56 | |||||
Future 3-5Y Total Revenue Growth Rate | 4.23 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.21 | |||||
9-Day RSI | 55.31 | |||||
14-Day RSI | 49.88 | |||||
6-1 Month Momentum % | 7.07 | |||||
12-1 Month Momentum % | 0.32 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.29 | |||||
Quick Ratio | 0.82 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 202.23 | |||||
Days Sales Outstanding | 73.02 | |||||
Days Payable | 90.46 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.42 | |||||
Dividend Payout Ratio | 0.35 | |||||
3-Year Dividend Growth Rate | 19.2 | |||||
Forward Dividend Yield % | 1.42 | |||||
5-Year Yield-on-Cost % | 2.55 | |||||
Shareholder Yield % | 2.18 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.03 | |||||
Operating Margin % | 16.68 | |||||
Net Margin % | 13.08 | |||||
FCF Margin % | 8.75 | |||||
ROE % | 10.03 | |||||
ROA % | 5.55 | |||||
ROIC % | 6.58 | |||||
ROC (Joel Greenblatt) % | 32.51 | |||||
ROCE % | 9.31 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 23.9 | |||||
Forward PE Ratio | 17.48 | |||||
PE Ratio without NRI | 24.07 | |||||
Shiller PE Ratio | 24.8 | |||||
Price-to-Owner-Earnings | 24.01 | |||||
PEG Ratio | 2.08 | |||||
PS Ratio | 3.12 | |||||
PB Ratio | 2.32 | |||||
Price-to-Tangible-Book | 20.25 | |||||
Price-to-Free-Cash-Flow | 35.7 | |||||
Price-to-Operating-Cash-Flow | 16.4 | |||||
EV-to-EBIT | 20.18 | |||||
EV-to-Forward-EBIT | 18.62 | |||||
EV-to-EBITDA | 13.39 | |||||
EV-to-Forward-EBITDA | 12.78 | |||||
EV-to-Revenue | 3.61 | |||||
EV-to-Forward-Revenue | 3.47 | |||||
EV-to-FCF | 39.8 | |||||
Price-to-Projected-FCF | 1.41 | |||||
Price-to-DCF (Earnings Based) | 1.41 | |||||
Price-to-DCF (FCF Based) | 2.73 | |||||
Price-to-Median-PS-Value | 1.08 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.17 | |||||
Price-to-Graham-Number | 4.74 | |||||
Earnings Yield (Greenblatt) % | 4.96 | |||||
FCF Yield % | 2.69 | |||||
Forward Rate of Return (Yacktman) % | 14.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Merck KGaA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 20,820 | ||
EPS (TTM) (€) | 6.26 | ||
Beta | 0.98 | ||
Volatility % | 28.13 | ||
14-Day RSI | 49.88 | ||
14-Day ATR (€) | 3.692301 | ||
20-Day SMA (€) | 152.315 | ||
12-1 Month Momentum % | 0.32 | ||
52-Week Range (€) | 134.3 - 176.25 | ||
Shares Outstanding (Mil) | 434.78 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Merck KGaA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Merck KGaA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Merck KGaA Frequently Asked Questions
What is Merck KGaA(XTER:MRK)'s stock price today?
The current price of XTER:MRK is €155.30. The 52 week high of XTER:MRK is €176.25 and 52 week low is €134.30.
When is next earnings date of Merck KGaA(XTER:MRK)?
The next earnings date of Merck KGaA(XTER:MRK) is 2024-08-01.
Does Merck KGaA(XTER:MRK) pay dividends? If so, how much?
The Dividend Yield %  of Merck KGaA(XTER:MRK) is 1.42% (As of Today), Highest Dividend Payout Ratio of Merck KGaA(XTER:MRK) was 0.48. The lowest was 0.2. And the median was 0.32. The  Forward Dividend Yield % of Merck KGaA(XTER:MRK) is 1.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |